Late breaking news: two additional DHHS guidelines changes. Department of Health and Human Services.

Research output: Contribution to journalArticle

Abstract

A recent revision was made in the Use of Antiretroviral Therapy for Adults and Adolescents Guidelines. Delavirdine is added to nevirapine as an acceptable or equivalent non-nucleoside reverse transcriptase inhibitor, in the Alternative Options category. In addition, invirase plus two nucleoside reverse transcriptase inhibitors, are demoted from the Alternative Options category.

Original languageEnglish (US)
Pages (from-to)5
Number of pages1
JournalThe Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
Volume10
Issue number3
StatePublished - 1998
Externally publishedYes

    Fingerprint

Cite this